These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 25886288)

  • 1. NAT1 and NAT2 genetic polymorphisms and environmental exposure as risk factors for oesophageal squamous cell carcinoma: a case-control study.
    Matejcic M; Vogelsang M; Wang Y; Iqbal Parker M
    BMC Cancer; 2015 Mar; 15():150. PubMed ID: 25886288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
    Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cigarette smoking, N-acetyltransferase genes and the risk of advanced colorectal adenoma.
    Moslehi R; Chatterjee N; Church TR; Chen J; Yeager M; Weissfeld J; Hein DW; Hayes RB
    Pharmacogenomics; 2006 Sep; 7(6):819-29. PubMed ID: 16981843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of NAT1 and NAT2 polymorphisms, tobacco smoking and meat consumption and risk of colorectal cancer.
    Sørensen M; Autrup H; Olsen A; Tjønneland A; Overvad K; Raaschou-Nielsen O
    Cancer Lett; 2008 Aug; 266(2):186-93. PubMed ID: 18372103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians.
    Gu J; Liang D; Wang Y; Lu C; Wu X
    Mutat Res; 2005 Mar; 581(1-2):97-104. PubMed ID: 15725609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H; Sigsgaard T; Wolf H; Autrup H
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma.
    Morton LM; Schenk M; Hein DW; Davis S; Zahm SH; Cozen W; Cerhan JR; Hartge P; Welch R; Chanock SJ; Rothman N; Wang SS
    Pharmacogenet Genomics; 2006 Aug; 16(8):537-45. PubMed ID: 16847422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence variants of NAT1 and NAT2 and other xenometabolic genes and risk of lung and aerodigestive tract cancers in Central Europe.
    McKay JD; Hashibe M; Hung RJ; Wakefield J; Gaborieau V; Szeszenia-Dabrowska N; Zaridze D; Lissowska J; Rudnai P; Fabianova E; Mates D; Foretova L; Janout V; Bencko V; Chabrier A; Hall J; Boffetta P; Canzian F; Brennan P
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):141-7. PubMed ID: 18199719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study testing the association between N-acetyltransferases 1 and 2 and risk of oral squamous cell carcinoma in Japanese people.
    Katoh T; Kaneko S; Boissy R; Watson M; Ikemura K; Bell DA
    Carcinogenesis; 1998 Oct; 19(10):1803-7. PubMed ID: 9806162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction.
    Taylor JA; Umbach DM; Stephens E; Castranio T; Paulson D; Robertson C; Mohler JL; Bell DA
    Cancer Res; 1998 Aug; 58(16):3603-10. PubMed ID: 9721868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of prostate cancer with rapid N-acetyltransferase 1 (NAT1*10) in combination with slow N-acetyltransferase 2 acetylator genotypes in a pilot case-control study.
    Hein DW; Leff MA; Ishibe N; Sinha R; Frazier HA; Doll MA; Xiao GH; Weinrich MC; Caporaso NE
    Environ Mol Mutagen; 2002; 40(3):161-7. PubMed ID: 12355549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk.
    Bouchardy C; Mitrunen K; Wikman H; Husgafvel-Pursiainen K; Dayer P; Benhamou S; Hirvonen A
    Pharmacogenetics; 1998 Aug; 8(4):291-8. PubMed ID: 9731715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of genetic polymorphisms of N-acetyltransferase 2 and susceptibility to esophageal cancer in north Indian population.
    Jain M; Kumar S; Lal P; Tiwari A; Ghoshal UC; Mittal B
    Cancer Invest; 2007 Aug; 25(5):340-6. PubMed ID: 17661210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.
    Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM
    Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between polymorphisms at N-acetyltransferase 1 (NAT1) & risk of oral leukoplakia & cancer.
    Majumder M; Ghosh S; Roy B
    Indian J Med Res; 2012 Oct; 136(4):605-13. PubMed ID: 23168701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetyltransferase 2 acetylator genotype-dependent N-acetylation of 4-aminobiphenyl in cryopreserved human hepatocytes.
    Habil MR; Doll MA; Hein DW
    Pharmacogenet Genomics; 2020 Apr; 30(3):61-65. PubMed ID: 31895247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
    García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
    Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Acetyltransferase 2 polymorphisms, cigarette smoking and alcohol consumption, and oral squamous cell cancer risk.
    Chen C; Ricks S; Doody DR; Fitzgibbons ED; Porter PL; Schwartz SM
    Carcinogenesis; 2001 Dec; 22(12):1993-9. PubMed ID: 11751430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation in N-acetyltransferases 1 and 2, cigarette smoking, and risk of non-Hodgkin lymphoma.
    Kilfoy BA; Zheng T; Lan Q; Han X; Holford T; Hein DW; Qin Q; Leaderer B; Morton LM; Yeager M; Boyle P; Zhao P; Chanock S; Rothman N; Zhang Y
    Cancer Causes Control; 2010 Jan; 21(1):127-33. PubMed ID: 19809881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meat and heterocyclic amine intake, smoking, NAT1 and NAT2 polymorphisms, and colorectal cancer risk in the multiethnic cohort study.
    Nöthlings U; Yamamoto JF; Wilkens LR; Murphy SP; Park SY; Henderson BE; Kolonel LN; Le Marchand L
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2098-106. PubMed ID: 19549810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.